Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 6.875

-2.2%

1:21 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	1/25/2007 8:40:39 AM
	Read Replies (1) of 269

7:31AM BioCryst Pharm initiates Phase II influenza clinical trial to evaluate Peramivir (BCRX) 10.49 : Co announces that it has initiated a Phase II clinical trial of peramivir, the co's lead influenza neuraminidase inhibitor, to determine the safety and efficacy of an intramuscular formulation of the drug in patients with influenza. Peramivir is in clinical development for the treatment of seasonal and potentially life- threatening human influenza.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next